CAS 2470126-25-9
:Sitagliptin N-Sulfate (sodium salt)
Description:
Sitagliptin N-Sulfate (sodium salt) is a chemical compound derived from sitagliptin, a medication primarily used in the management of type 2 diabetes. As a sodium salt, it is characterized by the presence of a sulfate group, which enhances its solubility and stability in aqueous solutions. This compound functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, playing a crucial role in increasing insulin secretion and decreasing glucagon levels in the bloodstream, thereby aiding in glycemic control. The molecular structure includes a sulfonate group, which contributes to its pharmacological properties. Sitagliptin N-Sulfate is typically administered orally and is well-absorbed, with a favorable pharmacokinetic profile. Its safety and efficacy have been established through clinical studies, making it a valuable therapeutic agent in diabetes management. Additionally, the compound is subject to regulatory oversight, ensuring its quality and consistency for therapeutic use. Overall, Sitagliptin N-Sulfate (sodium salt) represents an important advancement in diabetes treatment, with specific characteristics that enhance its functionality as a medication.
Formula:C16H16F6N5NaO4S
Synonyms:- [Synonyms]
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
